{"id":742687,"date":"2023-03-27T07:04:29","date_gmt":"2023-03-27T11:04:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/"},"modified":"2023-03-27T07:04:29","modified_gmt":"2023-03-27T11:04:29","slug":"biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/","title":{"rendered":"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass. and NESS ZIONA, Israel, March  27, 2023  (GLOBE NEWSWIRE) &#8212; BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, March 29th, 2023, at 8:00 a.m. ET, to report fourth quarter and full year 2022 financial results and provide business updates.<\/p>\n<p>To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xoAEsiWve_UOkoJI7b_Jlfh2eAwUmloSuXFEWdAS-NCgQuITF4u67hOYNFIMq81rCKvaGXrKnXX0M0Pj_9vipw==\" rel=\"nofollow noopener\" target=\"_blank\">www.biomx.com<\/a>.<\/p>\n<p>\n        <strong>About BiomX<\/strong>\n      <\/p>\n<p>BiomX is a clinical-stage company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xoAEsiWve_UOkoJI7b_Jlc9JZzpLQLAr_oWfJO7vPOUf6UPL9fR3mLInAUymzvNO5upR3eJdf_7RYMDFmrVXxQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.biomx.com<\/a>, the content of which does not form a part of this press release.<\/p>\n<p>BiomX, Inc.<br \/>Anat Primovich<br \/>Corporate Project Manager<br \/>+97250-6977228<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=up-YZAP3pZ4lePmMZN1Hd1CdPAbQFk8Tf8M-hc7fVsA29RJuJ1FXl1Om0aKJrEAa-DaWOkXNt7G0htG-B5M1Gw==\" rel=\"nofollow noopener\" target=\"_blank\">anatp@biomx.com<\/a><\/p>\n<p>Investor Relations:<br \/>LifeSci Advisors, LLC<br \/>John Mullaly<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fn2MwTMzVXtn2o3WE637qQabKYvm2777oSuW7s9qpnKIqArpmSRmlOI8u5ipd7-B6-wTxXi8sBWf2D8xLElEoFwejSdonEgEj0nN9ZMjzWG6VmNVySInVXRT7AMK0mpP\" rel=\"nofollow noopener\" target=\"_blank\">jmullaly@lifesciadvisors.com<\/a><\/p>\n<p>Source: BiomX Inc<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NDJkMDYxNzQtNzk1Ny00NDc2LTkwYmItYWYwY2JiMjA4ZTUwLTUwMDA2ODEyNA==\/tiny\/BiomX.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass. and NESS ZIONA, Israel, March 27, 2023 (GLOBE NEWSWIRE) &#8212; BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, March 29th, 2023, at 8:00 a.m. ET, to report fourth quarter and full year 2022 financial results and provide business updates. To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company\u2019s website at\u00a0www.biomx.com. About BiomX BiomX is a clinical-stage company developing both natural and engineered phage cocktails designed to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-742687","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. and NESS ZIONA, Israel, March 27, 2023 (GLOBE NEWSWIRE) &#8212; BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, March 29th, 2023, at 8:00 a.m. ET, to report fourth quarter and full year 2022 financial results and provide business updates. To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company\u2019s website at\u00a0www.biomx.com. About BiomX BiomX is a clinical-stage company developing both natural and engineered phage cocktails designed to &hellip; Continue reading &quot;BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T11:04:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023\",\"datePublished\":\"2023-03-27T11:04:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/\"},\"wordCount\":209,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/\",\"name\":\"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==\",\"datePublished\":\"2023-03-27T11:04:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/","og_locale":"en_US","og_type":"article","og_title":"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023 - Market Newsdesk","og_description":"CAMBRIDGE, Mass. and NESS ZIONA, Israel, March 27, 2023 (GLOBE NEWSWIRE) &#8212; BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, March 29th, 2023, at 8:00 a.m. ET, to report fourth quarter and full year 2022 financial results and provide business updates. To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company\u2019s website at\u00a0www.biomx.com. About BiomX BiomX is a clinical-stage company developing both natural and engineered phage cocktails designed to &hellip; Continue reading \"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-27T11:04:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023","datePublished":"2023-03-27T11:04:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/"},"wordCount":209,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/","name":"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==","datePublished":"2023-03-27T11:04:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTU4MSM1NDkyMTk2IzUwMDA2ODEyNA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomx-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-and-webcast-on-march-29th-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=742687"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742687\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=742687"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=742687"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=742687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}